Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Pain|December 1, 2000
Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic ratsMarie-Ange Coudoré-Civiale, Christine Courteix, Joseph Fialip, et al.European Journal of Pain (London, England)|August 6, 2002
Involvement of N-methyl-D-aspartate receptors in nociception in the cyclophosphamide-induced vesical pain model in the conscious ratMurielle Méen, Marie-Ange Coudoré-Civiale, Laurent Parry, et al.Journal of Evaluation in Clinical Practice|January 24, 2008
The uptake of technologies designed to influence medication safety in Canadian hospitalsMichael Saginur, Ian D Graham, Alan J Forster, et al.CMAJ Open|February 7, 2023
Extended dual antiplatelet therapy following percutaneous coronary intervention in clinically important patient subgroups: a systematic review and meta-analysisJesse Elliott, Shannon E Kelly, Zemin Bai, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2007
Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic reviewAlaa Rostom, Katherine Muir, Catherine Dubé, et al.BMJ Open|June 19, 2019
Dual antiplatelet therapy following percutaneous coronary intervention: protocol for a systematic reviewJesse Elliott, Shannon E Kelly, Zemin Bai, et al.The Canadian Journal of Cardiology|August 5, 2019
Optimal Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: An Umbrella ReviewJesse Elliott, Shannon E Kelly, Zemin Bai, et al.BMJ Open|April 6, 2017
Optimal duration of dual antiplatelet therapy following percutaneous coronary intervention: protocol for an umbrella reviewJesse Elliott, Shannon E Kelly, Zemin Bai, et al.Pageof 2